Insta
India To Have COVID-19 Vaccines From Six Companies In The Markets By End Of Year: Dr Harsh Vardhan
Health Minister Dr Harsh Vardhan (Facebook/@drharshvardhanofficial)
In what would be a big boost for the national effort to end the menace of the COVID-19 pandemic, India is likely to have six different vaccines in the market by end of the year as per the details made public by Union Minister for Health Dr Harsh Vardhan, reports Times of India.
Dr Harsh Vardhan yesterday (6 March) shared that around 24 pharma companies are conducting trials for COVID-19 vaccines presently and that vaccines from six different companies would be available by the year-end.
Dr Harsh Vardhan also shared that India is already supplying vaccines to 60 nations across the globe. This gains significance as India is supplying vaccines to other nations while also inoculating its population.
India has authorised the use of Serum Institute of India (SII) manufactured Covishield and Bharat Biotech developed Covaxin vaccines.
It should be noted that Covishield has been developed by British-Swedish pharmaceutical giant AstraZeneca in collaboration with the University of Oxford. Meanwhile, Covaxin has been indigenously developed by Bharat Biotech in a close collaboration with ICMR and Pune based National Institute of Virology.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
